NCT00303914已完成不适用
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,310
- 试验地点
- 32
- 主要终点
- Prevalence, severity, and interference due to physical and psychological symptoms experienced by cancer patients as assessed by MD Anderson Symptom Inventory at baseline and days 28-35 following initial assessment
研究概览
简要总结
RATIONALE: Questionnaires that assess symptoms caused by cancer and cancer therapy may help improve the ability to plan treatment for patients with invasive cancer to help them live longer and more comfortably.
PURPOSE: This clinical trial is studying symptoms caused by cancer and cancer therapy in patients with invasive breast, lung, prostate, or colorectal cancer.
详细描述
OBJECTIVES:
Primary
- Determine the prevalence, severity, and interference due to physical and psychological symptoms experienced (over a 4 to 5 week period) by patients with invasive primary breast, lung, prostate, or colorectal cancer who are being followed on an outpatient basis at ECOG institutions.
Secondary
- Determine if the number of symptom-related interventions are related to the providers' perception of symptom severity.
- Determine whether physical symptoms are more commonly prioritized and treated compared to psychological symptoms.
- Determine the percentage of patients who experience a significant reduction in moderate-to-severe symptoms and characterize the determinants of symptom relief.
- Determine the focus and scope of interventions chosen by oncologists to improve the symptom control of patients seen in outpatient clinics.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 120 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Prevalence, severity, and interference due to physical and psychological symptoms experienced by cancer patients as assessed by MD Anderson Symptom Inventory at baseline and days 28-35 following initial assessment
次要结局
- Number of symptom-related interventions related to the providers perception of symptom severity as assessed by The Revised Edmonton Staging System for cancer pain (rESS) at baseline and days 28-35 following initial assessment
- Percentage of patients who experience a significant reduction in moderate-to-severe symptoms and characterize the determinants of symptom relief
- Focus and scope of interventions chosen to improve symptom control
- Compare treatment priority based on physical or psychological symptoms
研究者
研究点 (32)
Loading locations...
相似试验
已完成
不适用
Internet Support for Cancer PatientsBreast CancerCancerProstate CancerNCT00710658Oslo University Hospital325
已完成
1 期
Improving Symptom Management for Cancer Patients and Their Caregivers Through InternetFatigueNCT01867723Oslo University Hospital560
Unknown
不适用
Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung CancerLung CancerNCT00242983National Hospital Organization Kinki-chuo Chest Medical Center
已完成
不适用
Impact of Cancer on the Physical and Psychological Well-being of Children in Mainland ChinaChildNCT02928731The University of Hong Kong425
Unknown
不适用
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine TumorsGastrointestinal Carcinoid TumorIslet Cell TumorMetastatic CancerNeoplastic SyndromeLung CancerNCT00454376National Cancer Institute (NCI)408